PL2456457T3 - Związki do inhibowania skurczu mięśni - Google Patents

Związki do inhibowania skurczu mięśni

Info

Publication number
PL2456457T3
PL2456457T3 PL10736634T PL10736634T PL2456457T3 PL 2456457 T3 PL2456457 T3 PL 2456457T3 PL 10736634 T PL10736634 T PL 10736634T PL 10736634 T PL10736634 T PL 10736634T PL 2456457 T3 PL2456457 T3 PL 2456457T3
Authority
PL
Poland
Prior art keywords
compounds
muscle contraction
inhibit muscle
inhibit
contraction
Prior art date
Application number
PL10736634T
Other languages
English (en)
Inventor
Sanz Nuria García
Den Nest Wim Van
Serraïma Cristina Carreño
Montiel Antonio Ferrer
Puche Juan Cebrián
Domenech Nuria Almiñana
Ballester Gregorio Fernández
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of PL2456457T3 publication Critical patent/PL2456457T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL10736634T 2009-07-24 2010-07-23 Związki do inhibowania skurczu mięśni PL2456457T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES200930501 2009-07-24
US22876709P 2009-07-27 2009-07-27
PCT/EP2010/004530 WO2011009626A1 (en) 2009-07-24 2010-07-23 Compounds which inhibit muscle contraction
EP10736634.6A EP2456457B1 (en) 2009-07-24 2010-07-23 Compounds which inhibit muscle contraction

Publications (1)

Publication Number Publication Date
PL2456457T3 true PL2456457T3 (pl) 2015-04-30

Family

ID=43498785

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10736634T PL2456457T3 (pl) 2009-07-24 2010-07-23 Związki do inhibowania skurczu mięśni

Country Status (14)

Country Link
US (1) US8946166B2 (pl)
EP (1) EP2456457B1 (pl)
JP (1) JP5782439B2 (pl)
KR (1) KR101757946B1 (pl)
CN (1) CN102470160B (pl)
AU (1) AU2010275688B2 (pl)
BR (1) BR112012001322B1 (pl)
CA (1) CA2768386A1 (pl)
ES (1) ES2527022T3 (pl)
IN (1) IN2012DN01584A (pl)
MX (1) MX2012001077A (pl)
PL (1) PL2456457T3 (pl)
TW (1) TWI487533B (pl)
WO (1) WO2011009626A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2473559C1 (ru) * 2011-10-26 2013-01-27 Общество с ограниченной ответственностью "Синейро" Пептид аземиопсин, избирательно взаимодействующий с никотиновыми холинорецепторами мышечного типа и пригодный для использования в качестве мышечного релаксанта в медицине и косметологии
EP2649985A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649983A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
EP2649984A1 (en) * 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
ES2660901T3 (es) * 2012-04-13 2018-03-26 Lubrizol Advanced Materials, Inc. Compuestos que inhiben la exocitosis neuronal (II)
WO2014015179A1 (en) * 2012-07-20 2014-01-23 Sophoro Biotechnologies, Llc Carbohydrate esters as inducers for gene expression
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
US20150110908A1 (en) 2013-10-21 2015-04-23 Ocusoft, Inc. Compositions, Kits, and Methods for Ameliorating Oculoplastic Post-Procedural Effects
US20160250298A1 (en) 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
CA2965525A1 (en) 2014-10-31 2016-05-06 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces
EP3371238A1 (en) 2015-11-05 2018-09-12 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
WO2017136600A1 (en) 2016-02-04 2017-08-10 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
WO2017197382A1 (en) * 2016-05-13 2017-11-16 Gardner Mary Treating of side-effects resulting from chemodenervation
CA3087881A1 (en) 2017-01-17 2018-07-26 Michael David FORREST Therapeutic inhibitors of the reverse mode of atp synthase
CA3099077A1 (en) 2017-07-13 2019-01-17 Michael David FORREST Therapeutic modulators of the reverse mode of atp synthase
EP3661538A4 (en) 2017-08-03 2021-07-14 Alastin Skincare, Inc. COMPOSITIONS AND PROCEDURES FOR IMPROVING SLEEPING SKIN AND BODY CONTOUR
CN107898658A (zh) * 2017-12-13 2018-04-13 南昌师范学院 六胜肽祛皱增效原液组合物
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
CN108904414A (zh) * 2018-10-10 2018-11-30 广州科盈化妆品有限公司 一种快速祛皱眼霜
EP4393502A2 (en) * 2018-12-26 2024-07-03 Skinmed Co., Ltd. Acetylcholine receptor inhibitory peptides and uses thereof
EP3906013A1 (en) 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
CN110426476A (zh) * 2019-08-15 2019-11-08 珠海伊斯佳科技股份有限公司 一种化妆品中乙酰基六肽-8含量的测定方法
CN114478297A (zh) * 2020-11-12 2022-05-13 山东省科学院菏泽分院 一种扑炎痛的合成制备方法
KR102584000B1 (ko) 2021-01-19 2023-10-06 김기연 신경전달물질을 조절하는 펩타이드를 포함하는 스포츠 로션 조성물
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
US20250325469A1 (en) 2021-01-24 2025-10-23 Michael David FORREST Inhibitors of atp synthase - cosmetic and therapeutic uses
EP4501944A4 (en) * 2022-03-28 2025-10-08 Shenzhen Winkey Tech Co Ltd POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND THEIR USE
CN116003518B (zh) * 2023-01-10 2023-09-29 深圳市维琪科技股份有限公司 经设计的肽及其组合物和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169074B1 (en) 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
US6780413B2 (en) 1996-09-19 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders
ES2160485B1 (es) 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
US7964630B2 (en) 2004-11-02 2011-06-21 Dsm Ip Assets B.V. Topical application agents against mimic and age-related wrinkles

Also Published As

Publication number Publication date
ES2527022T3 (es) 2015-01-19
TW201116289A (en) 2011-05-16
BR112012001322B1 (pt) 2022-05-03
WO2011009626A1 (en) 2011-01-27
IN2012DN01584A (pl) 2015-06-05
JP5782439B2 (ja) 2015-09-24
BR112012001322A2 (pt) 2020-08-11
AU2010275688B2 (en) 2014-06-19
US20120121675A1 (en) 2012-05-17
AU2010275688A1 (en) 2012-02-02
CN102470160B (zh) 2015-03-18
CA2768386A1 (en) 2011-01-27
MX2012001077A (es) 2012-06-12
TWI487533B (zh) 2015-06-11
KR20120104159A (ko) 2012-09-20
KR101757946B1 (ko) 2017-07-14
EP2456457B1 (en) 2014-10-22
JP2013500245A (ja) 2013-01-07
US8946166B2 (en) 2015-02-03
CN102470160A (zh) 2012-05-23
HK1170415A1 (en) 2013-03-01
EP2456457A1 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
ZA201107772B (en) Substituted spiro-amide compounds
GB0907425D0 (en) Compounds
EP2393493A4 (en) LINKS
IL219248A0 (en) Compounds
GB0907515D0 (en) Compounds
GB0914856D0 (en) Compounds
GB0915892D0 (en) Compounds
ZA201205726B (en) Substituted naphthalenyl-pyrimidine compounds
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0909672D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0911000D0 (en) Compounds
EP2443115A4 (en) COMPOUNDS
GB0905060D0 (en) Compounds
GB0905054D0 (en) Compounds
GB0912238D0 (en) Compounds
GB0904729D0 (en) Compounds
GB0915789D0 (en) Compounds
GB0908941D0 (en) Compounds
GB0913248D0 (en) Compounds
GB0915686D0 (en) Compounds
GB0902796D0 (en) Compounds
GB0904746D0 (en) Compounds